Gonif

Gonif is a prescription injectable solution that contains the active ingredient cefuroxime sodium. It is a second‑generation cephalosporin antibiotic supplied in an unspecified strength for intramuscular or intravenous administration. Marketed in the European Union, Gonif works by inhibiting bacterial cell‑wall synthesis, making it suitable for treating a range of bacterial infections under medical supervision.

Gonif is indicated for the treatment of several bacterial infections where a broad‑spectrum cephalosporin is appropriate.

- Respiratory tract infections such as pneumonia and bronchitis - Urinary tract infections, including uncomplicated cystitis - Skin and soft‑tissue infections like cellulitis - Meningitis caused by susceptible organisms - Gonorrhea and other sexually transmitted infections - Otitis media in pediatric and adult patients

Side effects of Gonif vary in frequency and severity. Patients should be aware of both common and serious reactions.

Common: - Nausea or vomiting - Diarrhea or loose stools - Injection site pain or erythema - Headache - Transient elevation of liver enzymes

Serious: - Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome) - Clostridioides difficile‑associated diarrhea - Hemolytic anemia - Renal impairment or interstitial nephritis

Before using Gonif, clinicians should consider several safety factors to minimize risk.

- Assess patient history for penicillin or cephalosporin allergy - Use caution in patients with renal dysfunction; dose adjustment may be required - Monitor liver function tests during prolonged therapy - Evaluate for potential overgrowth of non‑susceptible organisms, especially C. difficile - Avoid use in neonates with hyperbilirubinemia due to risk of kernicterus - Discuss pregnancy and breastfeeding status with the prescriber, as safety data are limited

Gonif may interact with other medicines, influencing efficacy or safety. Some combinations should be avoided, while others require careful monitoring.

Avoid: - Concurrent use with other nephrotoxic agents (e.g., aminoglycosides, amphotericin B) - Probenecid, which can increase cefuroxime plasma concentrations - Warfarin, as cefuroxime may enhance anticoagulant effects

Use with caution: - Diuretics, due to potential electrolyte disturbances - Oral contraceptives, as antibiotics may reduce effectiveness - Antacids containing aluminum or magnesium, which may affect absorption when given orally (not applicable to injectable form but noted for completeness)